DexCom Inc. (NASDAQ:DXCM) is one of the best growth stocks to buy in 2026. On December 2, Morgan Stanley upgraded DexCom to Overweight from Equal Weight with a price target of $75, which was up from ...

DexCom, which has underperformed its medical equipment and S&P 500 peers in a big way in 2025, could be staring at better prospects next year. Stelo is facing vast and underpenetrated prediabetes and ...

Share on Pinterest An FDA panel has called for an easing of restrictions on testosterone replacement therapy (TRT). Image Credit: Malorny/Getty Images A Food and Drug Administration (FDA) expert panel ...

Executive Editor David Carnoy has been a leading member of CNET's Reviews team since 2000. He covers the gamut of gadgets and is a notable reviewer of mobile accessories and portable audio products, ...

We've been here before: congressional Democrats and Republicans sparring over the future of the Affordable Care Act. But this time there's an extra complication. Though it's the middle of open ...